Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The Ad26.Mos4.HIV vaccine – which uses the same adenoviral technology as J&J's COVID-19 vaccine and targets four HIV antigens – showed that the shot was safe but unable to meet its target of ...

A trial viewed as the best hope of finding an effective HIV vaccine this decade has ended in failure in another major setback for the field. The PrEPVacc trial in East and Sothern Africa is ...

including a clinical trial to help youth living with or at risk of HIV access vaccines, a trauma-informed study on the role ...

In the mITT group, seven volunteers, five in the vaccinated and two in the placebo group, were found to be seropositive for HIV at the time of the first vaccine administration and were excluded ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Merck linkurl:halted;http://tinyurl.com/2t76sm its Phase IIb clinical trials of an HIV vaccine last week, after data showed a lack of efficacy. According to a news ...

Clifford Lane, a 45-year veteran of the NIH and close confidant of Fauci as NIAID deputy director for clinical research, and NIAID microbiology and infectious diseases director Emily Erbelding, have ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...